5 Biggest Penny Stock Gainers on the Radar for March 19

biggest penny stock gainers

Despite the current situation with the stock market, people are still on the lookout for the biggest penny stock gainers today, and in order to do that, one needs to track the market closely. The stock markets have been in a tailspin over the past week. After recovering from its biggest fall since 1987 on Tuesday, the Dow Jones tanked again on Wednesday.

However, despite widespread fears that things were going to tank further, the stock market actually went into positive territory today. The recovery of sorts was primarily powered by tech stocks.

Penny stocks have always been a popular category of stocks for plenty of investors, and it could be worthwhile for investors to take a look at some of the penny stocks that are soaring today on the back of the recovery.

Here is a quick look at the 5 biggest penny stocks gainers on Thursday morning.

Biggest Penny Stock Gainers: Aytu Bioscience Inc (NASDAQ:AYTU)

The first stock that could be considered by investors is Aytu Bio, which has made significant gains today. The company announced today that it has successfully extended its distributions rights for its COVID-19 IgG/IgM Rapid Test. It should be noted that the test is clinically validated and has resulted in a lot of attention for the company over the past days.

The test successfully delivers results within two to ten minutes and has been licensed from the Hong Kong-based company L.B. Resources. By way of this particular amendment, the company will now be able to distribute the test in the United States, Mexico, and Canada. The stock soared by 16% on the back of this announcement.

Biggest Penny Stock Gainers: Soligenix, Inc. (NASDAQ:SNGX)

Biggest Penny Stock Gainers

Soligenix has emerged as one of the biggest penny stock gainers this morning after the company announced preliminary top-line results from the Phase 3 clinical trial of its product, SGX 301.

The medicine in question is meant to treat patients suffering from cutaneous T-cell lymphoma (CTCL). According to the data from the study, the medicine managed to hit its primary endpoint, which resulted in positive stock movement for SNGX this morning.

SNGX stock grew 12% in the early morning session on Thursday, but it remains to be seen if it can extend these gains throughout the rest of the day.

>> 4 Gold Penny Stocks Losing Momentum as Investors Turn Bearish

Biggest Penny Stock Gainers: Waitr Holdings Inc (NASDAQ:WTRH)

Meal kit delivery firm Waitr Holdings has been on fire this week, soaring by 1,100% since Monday. WTRH stock continued on its merry ways this morning, recording gains of 95% so far.

Due to the coronavirus pandemic, many restaurants have been closed down, and thousands of people from across the United States are now working from home. In such a situation, there could be high demand for the meal kits from Waitr, which explains the company’s stock growth.

Investors may want to keep an eye on WTRH stock.

Biggest Penny Stock Gainers: Chanticleer Holdings (NASDAQ:BURG)

Another stock to emerge in the spotlight is Chanticleer Holdings. BURG stock has soared by 375% this week so far, and this morning, it gained even more after the company announced the results of a key shareholder vote.

Chanticleer, which operates restaurant brands across the country, announced that its shareholders voted in favor of all the proposals at a special meeting recently held. Some of the proposals included the merger with Sonnet BioTherapeutics Inc and the spinoff of the restaurant business. After the announcement was made this morning, BURG stock soared by 165%.

Biggest Penny Stock Gainers: Moleculin Biotech Inc (NASDAQ:MBRX)

Biggest Penny Stock Gainers

Last but not least, Moleculin Biotech stock is soaring today after the company announced that one of its products could prove to be a medicine for treating coronavirus infection. Moleculin has reached an agreement with the University of Texas Medical Branch at Galveston by way of which its molecular inhibitors, such as WP 1122, are going to be tested against a wide range of viruses, including the coronavirus.

The announcement resulted in a sensational surge in MBRX stock this morning, which gained 48%.

>> Read More Penny Stock News

Featured image: DepositPhotos © Rangizzz

Please See Disclaimer


Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of Microsmallcap.com or its officers. The author is wholly responsible for the validity of all statements. Microsmallcap.com was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay Microsmallcap.com to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Microsmallcap.com's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. Microsmallcap.com does not render general or specific investment advice. Any information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Microsmallcap.com does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.